Top Stories Novo Nordisk Stock Surges on Half-Price Ozempic Deal, FDA Approval BREAKING: Novo Nordisk’s stock is surging following a 50% discount on its popular weight-loss drug, Ozempic. This urgent development comes as the Danish pharmaceutical... Editorial3 hours ago